Last reviewed · How we verify
V - C+V - C
V-C+V-C is a combination product containing vitamins and minerals that provides nutritional supplementation.
V-C+V-C is a combination product containing vitamins and minerals that provides nutritional supplementation. Used for Nutritional supplementation and deficiency prevention.
At a glance
| Generic name | V - C+V - C |
|---|---|
| Sponsor | IlDong Pharmaceutical Co Ltd |
| Drug class | Vitamin and mineral supplement |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplementation |
| Phase | FDA-approved |
Mechanism of action
This is a multivitamin and mineral supplement formulation marketed by IlDong Pharmaceutical. The exact composition is not clearly specified in available data, but such products typically contain essential vitamins and minerals to address nutritional deficiencies or support general health maintenance.
Approved indications
- Nutritional supplementation and deficiency prevention
Common side effects
Key clinical trials
- Conventional vs Pulsed RF in Coccydynia (NA)
- Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia (PHASE1)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) (PHASE2)
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (PHASE2)
- A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults (NA)
- Clinical Assessment of Viscosity-Modified Composite Resins: Preheated, Sonic Activated, and Flowable Resins in Class V Restorations (NA)
- Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- V - C+V - C CI brief — competitive landscape report
- V - C+V - C updates RSS · CI watch RSS
- IlDong Pharmaceutical Co Ltd portfolio CI